by David Rubin | Jun 7, 2023 | In the Press
Click here to listen to Dr. Rubin discuss the importance of head-to-head and comparative trials, combination therapies, optimization with timing, escalation and de-escalation, and how we should approach new therapies.
by David Rubin | Jun 7, 2023 | In the Press
Intestinal ultrasound (IUS) is a disease monitoring modality for IBD that is new to the United States. Dr. Noa Krugliak Cleveland is one of just a handful of experts in the country on IUS. Click here to listen to the full conversation where she provides an overview of...
by David Rubin | Jun 7, 2023 | In the Press
Click here to read Conference Coverage on Dr. Rubin’s talk at AIBD Virtual Regionals 2023, “JAK Inhibitors: Efficacy and Safety.” He details the pivotal clinical trials that help us understand JAK-inhibitors, as well as real-world evidence of their...
by David Rubin | Apr 10, 2023 | In the Press
Click here to watch the full video of Dr. Rubin’s presentation on exit strategies from maintenance therapy, including discussion of the reasons for why, when, how, and if you should stop IBD therapy with specific focus on biologics, 5-ASA, and...
